Skip to main content

RETRACTION article

Front. Pharmacol., 16 April 2018
Sec. Cancer Molecular Targets and Therapeutics
Volume 9 - 2018 | https://doi.org/10.3389/fphar.2018.00400

Retraction: Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

This article is a retraction of:

  1. Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

    1. Read original article
\r\nFrontiers Editorial Office*Frontiers Editorial Office*

A retraction of the Original Research Article
Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

by Prasad, S., Tyagi, A. K., Siddik, Z. H., and Aggarwal, B. B. (2017). Front. Pharmacol. 8:871. doi: 10.3389/fphar.2017.00871

Following publication, concerns were raised regarding the scientific validity of the article. An investigation was therefore conducted in accordance with our established procedures. Following provision of raw data by the authors, the Chief Editor concluded that aspects of the paper's conclusions and assertions were not sufficiently supported by the findings from the material provided. Namely that inconsistencies in experimental rigour preclude confirmation of the conclusion of the article.

The retraction of the article was approved by the Chief Editors of Pharmacology and the Editor-in-Chief of Frontiers.

The authors agree to the retraction.

Citation: Frontiers Editorial Office (2018) Retraction: Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric. Front. Pharmacol. 9:400. doi: 10.3389/fphar.2018.00400

Received: 06 April 2018; Accepted: 06 April 2018;
Published: 16 April 2018.

Approved by: Giuseppe Giaccone, Georgetown University, United States

Copyright © 2018 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, ZWRpdG9yaWFsLm9mZmljZUBmcm9udGllcnNpbi5vcmc=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.